Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 407
6
Diseases
5
Unique genes
0.367
Avg. similarity score
Continuous spike and wave during sleep syndrome
Most-connected disease (5 links)
Disease
Searched: Epilepsy with neurodevelopmental defects
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Epilepsy with neurodevelopmental defects
Continuous spike and wave during sleep syndrome
Focal epilepsy with speech disorder and impaired intellectual development
Landau-kleffner syndrome
Continuous spike and wave during slow wave sleep syndrome
Gastric mantle cell lymphoma
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Continuous spike and wave during sleep syndrome | 5 | 5 | 1 |
| Epilepsy with neurodevelopmental defects | 5 | 5 | 1 |
| Focal epilepsy with speech disorder and impaired intellectual development | 5 | 5 | 1 |
| Landau-kleffner syndrome | 5 | 5 | 1 |
| Continuous spike and wave during slow wave sleep syndrome | 4 | 4 | 2 |
| Gastric mantle cell lymphoma | 4 | 4 | 4 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GRIN2A | 6 / 6 | Continuous spike and wave during sleep syndrome, Continuous spike and wave during slow wave sleep syndrome, Epilepsy with neurodevelopmental defects, Focal epilepsy with speech disorder and impaired intellectual development and 2 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| MicroRNAs in cancer | KEGG | 3 / 311 | 23.2× | 1.65e-4 | 2.83e-3 ✓ sig. |
| Human papillomavirus infection | KEGG | 3 / 333 | 21.6× | 2.03e-4 | 3.32e-3 ✓ sig. |
| p53 signaling pathway | KEGG | 2 / 75 | 64.1× | 3.80e-4 | 5.40e-3 ✓ sig. |
| Endocrine resistance | KEGG | 2 / 99 | 48.5× | 6.62e-4 | 8.28e-3 ✓ sig. |
| Thyroid hormone signaling pathway | KEGG | 2 / 122 | 39.4× | 1.00e-3 | 1.14e-2 ✓ sig. |
| FoxO signaling pathway | KEGG | 2 / 133 | 36.1× | 1.19e-3 | 1.29e-2 ✓ sig. |
| Breast cancer | KEGG | 2 / 148 | 32.5× | 1.47e-3 | 1.52e-2 ✓ sig. |
| Cellular senescence | KEGG | 2 / 157 | 30.6× | 1.65e-3 | 1.66e-2 ✓ sig. |
| Cell cycle | KEGG | 2 / 158 | 30.4× | 1.68e-3 | 1.67e-2 ✓ sig. |
| Defective LFNG causes SCDO3 | Reactome | 1 / 5 | 480× | 2.08e-3 | 1.96e-2 ✓ sig. |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | Reactome | 1 / 5 | 480× | 2.08e-3 | 1.96e-2 ✓ sig. |
| Sensing of DNA Double Strand Breaks | Reactome | 1 / 6 | 400× | 2.50e-3 | 2.23e-2 ✓ sig. |
| PTK6 Regulates Cell Cycle | Reactome | 1 / 6 | 400× | 2.50e-3 | 2.23e-2 ✓ sig. |
| Pre-NOTCH Processing in Golgi | Reactome | 1 / 6 | 400× | 2.50e-3 | 2.23e-2 ✓ sig. |
| Assembly and cell surface presentation of NMDA receptors | Reactome | 1 / 6 | 400× | 2.50e-3 | 2.23e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| animal organ regeneration | GO:0031100 | 2 / 28 | 267× | 2.16e-5 | 9.80e-4 ✓ sig. |
| positive regulation of apoptotic process | GO:0043065 | 3 / 326 | 34.4× | 5.13e-5 | 1.88e-3 ✓ sig. |
| liver development | GO:0001889 | 2 / 87 | 85.9× | 2.12e-4 | 5.31e-3 ✓ sig. |
| protein catabolic process | GO:0030163 | 2 / 97 | 77.1× | 2.64e-4 | 6.20e-3 ✓ sig. |
| coronary sinus valve morphogenesis | GO:0003182 | 1 / 1 | 3,737× | 2.68e-4 | 6.25e-3 ✓ sig. |
| regulation of cardioblast proliferation | GO:0003264 | 1 / 1 | 3,737× | 2.68e-4 | 6.25e-3 ✓ sig. |
| Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | GO:0003270 | 1 / 1 | 3,737× | 2.68e-4 | 6.25e-3 ✓ sig. |
| foregut morphogenesis | GO:0007440 | 1 / 1 | 3,737× | 2.68e-4 | 6.25e-3 ✓ sig. |
| venous endothelial cell differentiation | GO:0060843 | 1 / 1 | 3,737× | 2.68e-4 | 6.25e-3 ✓ sig. |
| response to ethanol | GO:0045471 | 2 / 110 | 68.0× | 3.39e-4 | 7.32e-3 ✓ sig. |
| endocardium morphogenesis | GO:0003160 | 1 / 2 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| coronary vein morphogenesis | GO:0003169 | 1 / 2 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| cardiac right atrium morphogenesis | GO:0003213 | 1 / 2 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| growth involved in heart morphogenesis | GO:0003241 | 1 / 2 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |
| negative regulation of cell proliferation involved in heart valve morphogenesis | GO:0003252 | 1 / 2 | 1,869× | 5.35e-4 | 9.88e-3 ✓ sig. |